These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3563448)

  • 21. [A classification system for HTLV-III infected patients].
    Solbach W
    Fortschr Med; 1986 Sep; 104(36):665-6. PubMed ID: 3639836
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems posed by the patient with positive serology for the HTLV-III/LAV retrovirus].
    Zulaica D; Arrizabalaga J
    Med Clin (Barc); 1987 Jan; 88(3):117-22. PubMed ID: 3821274
    [No Abstract]   [Full Text] [Related]  

  • 23. Host immunity and the course of HIV infection.
    Bentwich Z; Wainberg MA
    Isr J Med Sci; 1993 Oct; 29(10 Suppl):34-6. PubMed ID: 8244678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possibilities of vaccine prevention and virostatic therapy in HTLV-III/LAV infection].
    Goebel FD
    Verh Dtsch Ges Inn Med; 1986; 92():341-3. PubMed ID: 3643689
    [No Abstract]   [Full Text] [Related]  

  • 25. Anergy and human immunodeficiency virus infection.
    Hegde HR; Robbins SM
    Med Hypotheses; 2001 Mar; 56(3):376-80. PubMed ID: 11359364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunologic restoration in patients with AIDS. Requiem for prophylaxis].
    Peña JM; Miró JM
    Med Clin (Barc); 1999 Oct; 113(10):375-8. PubMed ID: 10562941
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epidemiology and immunological study of LAV virus infection].
    Gluckman JC; Brunet JB
    Rev Prat; 1986 Apr; 36(21):1157-62. PubMed ID: 3022368
    [No Abstract]   [Full Text] [Related]  

  • 28. AIDS vaccines: back to 'plan A'.
    Check E
    Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
    Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen presentation and related immunological aspects of HIV-1 vaccines.
    Steinman RM; Germain RN
    AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of HTLV III/LAV from drug addicts in Palermo.
    Romano N; Portera M; Vitale F; Russo Alesi D; Torregrossa MV; Perrera G
    Microbiologica; 1987 Jan; 10(1):73-80. PubMed ID: 3646455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [AIDS: risk due to the endogenous immune system. HIV is not primarily cytopathic].
    Moosmann EB
    Fortschr Med; 1995 Apr; 113(11):30, 32. PubMed ID: 7768481
    [No Abstract]   [Full Text] [Related]  

  • 33. Classification of HTLV-III/LAV-related diseases in children.
    Wykoff RF
    J Infect Dis; 1986 Jun; 153(6):1181-2. PubMed ID: 3009648
    [No Abstract]   [Full Text] [Related]  

  • 34. Waltzing HIV-tilda.
    Schooley RT
    Arch Intern Med; 1988 Apr; 148(4):778. PubMed ID: 3355296
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acquired immunodeficiency syndrome (a clinical case)].
    Zimin IuI; Potekaev NS; Shuginina EA; Parfanovich MI
    Ter Arkh; 1987; 59(7):42-5. PubMed ID: 3672358
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acquired immune deficiency syndrome: an infection complicated by more infections].
    Latorre Capella X; Gatell Artigas JM
    Med Clin (Barc); 1986 Jan; 86(3):120-2. PubMed ID: 3959645
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hiv and AIDS infection. A. History, definition and classification].
    Cran S
    Acta Urol Belg; 1993; 61(1-2):353-61. PubMed ID: 8517255
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV infection. Epidemiology, screening, prevention, main immunological abnormalities, prognostic biological markers, classification (evolutive staging)].
    Raffi PF
    Rev Prat; 1997 Jun; 47(12):1347-55. PubMed ID: 9248102
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
    Aidoo M; Nishiwaki O; Akari H; Brandful JA; Ampofo W; Hayami M; Ayisi NK
    West Afr J Med; 1994; 13(3):150-1. PubMed ID: 7841103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.